Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 560-566

  Franz, Wolfgang M ^a   Rothmann, Thomas ^b   Frey, Norbert ^a   Katus, Hugo A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adenovirus; Gene therapy; Heart; Myocardium; Myosin heavy chain; Myosin light chain; Promoter; Rat

Indexed keywords

MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GENE TARGETING; GENE TRANSFER; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART ATRIA; HEART VENTRICLES; MUSCLE, SKELETAL; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030831415     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00154-5     Document Type: Article

References (32)

1. Johns DC, Nuss HB, Chiamvimonvat N, Ramza BM, Marban E, Lawrence JH Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). J Clin Invest. 96:1995;1152-1158.
2. Giordano FJ, Ping P, McKirnan MDet al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med. 2:1996;534-539.
3. Kass Eisler A, Falck Pedersen E, Alvira Met al. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci USA. 90:1993;11498-11502.
4. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res. 73:1993;1202-1207.
5. Barr E, Carroll J, Kalynych AMet al. Efficient catheter-mediated gene transfer into the heart using replication defective adenovirus. Gene Ther. 1:1994;51-58.
6. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy. Proc Natl Acad Sci USA. 91:1994;4407-4411.
7. Huard J, Lochmüller H, Acsadi G, Jani A, Massie B, Karpati G The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther. 2:1995;107-115.
8. Krougliak V, Graham FL Development of cell lines capable of complementing E1, E4 and protein IX defective adenovirus type 5 mutants. Hum Gene Ther. 6:1995;1575-1586.
9. Wang Q, Jia XC, Finer MH A packaging cell line for propagation of recombinant adenovirus containing two lethal gene-region deletions. Gene Ther. 2:1995;775-783.
10. Yeh P, Dedieu JF, Orsini C, Vigne E, Denefle P, Perricaudet M Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. J Virol. 70:1996;559-565.
11. Engelhardt JF, Ye X, Doranz B, Wilson JM Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 91:1994;6196-6200.
12. Yang Y, Nunes FA, Berencsi K, Gonczol E, Engelhardt JF, Wilson JM Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Gen. 7:1994;362-369.
13. Stradford-Perricaudet LD, Makeh I, Perricaudet M, Briand P Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 90:1992;626-630.
14. Kass Eisler A, Falck Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA The impact of developmental stage, route of administration and the immune system on adenovirus mediated gene transfer. Gene Ther. 1:1994;395-402.
15. Franz WM, Breves D, Klingel K, Brem G, Hofschneider PH, Kandolf R Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice. Circ Res. 73:1993;629-638.
16. Franz WM, Brem G, Katus HA, Klingel K, Hofschneider PH, Kandolf R Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic mice. Cardioscience. 5:1994;235-243.
17. Rothmann T, Katus HA, Hartong R, Perricaudet M, Franz WM Heart muscle-specific gene expression using replication defective recombinant adenoviurs. Gene Ther. 3:1996;919-926.
18. Subramaniam A, Jones WK, Gulick J, Wert S, Neumann J, Robbins J Tissue specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. J Biol Chem. 266:1991;24613-24620.
19. Subramaniam A, Gulick J, Neumann J, Knotts S, Robbins J Transgenic analysis of the thryoid elements in the alpha-cardiac myosin heavy chain gene promoter. J Biol Chem. 268:1993;4331-4336.
20. Mahdavi V, Cahmber AP, Nadal-Ginard B Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci USA. 81:1984;2626-2630.
21. Fallaux FJ, Kranenburg O, Cramer SJet al. Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther. 7:1996;215-222.
22. Bett AJ, Haddara W, Prevec L, Graham FL An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci USA. 91:1994;8802-8806.
23. Zhang WW, Koch PE, Roth JA Detection of wild-type contamination in a recombinant adenoviral preparation by PCR. BioTechniques. 18:1995;444-447.
24. Ausbel JM, Brent R, Kingston RR, et al. Current Protocols in Molecular Biology. New York: Greene and Wiley, 1989.
25. Hearing P, Shenk T The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell. 33:1983;695-703.
26. Hearing P, Samulski RJ, Wishart WL, Shenk T Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J Virol. 61:1987;2555-2558.
27. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol. 7:1987;725-737.
28. Henderson SA, Spencer M, Sen A, Kumar C, Siddiqui MA, Chien KR Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. J Biol Chem. 264:1989;1842-1848.
29. Acsadi G, Jani A, Massie Bet al. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Gen. 3:1994;579-584.
30. Quantin B, Perricaudet LD, Tajabkhsh S, Mandel JL Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA. 89:1992;2581-2584.
31. Bessereau JL, Stratford-Perricaudet LD, Piette J, Le Poupon C, Changeux JP In vivo and in vitro analysis of electrical activity-dependent expression of muscle acetylcholione receptor genes using adenovirus. Proc Natl Acad Sci USA. 91:1994;1304-1308.
32. Lompre AM, Nadal-Ginard B, Mahdavi V Expression of the cardiac ventricular α- and β-myosin heavy chain genes is developmentally and hormonally regulated. J Biol Chem. 259:1984;6437-6446.